Precigen, Inc. (PGEN) Financials
PGEN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 151.0 million | 41.6 million |
2023-09-30 | 190.7 million | 43.0 million |
2023-06-30 | 207.5 million | 41.3 million |
2023-03-31 | 241.5 million | 57.4 million |
PGEN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -16.8 million | 8.6 million |
2023-09-30 | -17.2 million | 2.3 million |
2023-06-30 | -15.9 million | 2.2 million |
2023-03-31 | -18.5 million | 3.1 million |
PGEN Net Income
No data available :(
PGEN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 62.9 million | - | 7.1 million |
2023-09-30 | 73.8 million | - | 7.4 million |
2023-06-30 | 88.4 million | - | 8.0 million |
2023-03-31 | 104.1 million | - | 7.9 million |
PGEN Shares Outstanding
PGEN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 1.0 million | 13.0 million | 10.3 million | - |
2023-09-30 | 236000 | 12.6 million | 9.2 million | - |
2023-06-30 | 101000 | 11.9 million | 9.3 million | - |
2023-03-31 | 154000 | 12.2 million | 11.6 million | - |
PGEN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 1.2 million | 2.6 million |
2023-09-30 | 16.7 million | 1.5 million |
2023-06-30 | 1.8 million | 1.7 million |
2023-03-31 | 1.9 million | 1.5 million |
PGEN
Price: $1.41
52 week price:
Earnings Per Share: -0.39 USD
P/E Ratio: -3.84
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 4.3 million
Market Capitalization: 348.5 million